As the FK506-binding domain of FKBP52 is involved in APP binding, it is conceivable that immunophilin ligands such as FK506 and rapamycin may associate with Alzheimer disease as well. Here, FKBP4 is linked to early-onset autosomal dominant Alzheimer disease.